Product NDC: | 64679-634 |
Proprietary Name: | Octreotide acetate |
Non Proprietary Name: | Octreotide acetate |
Active Ingredient(s): | 200 ug/mL & nbsp; Octreotide acetate |
Administration Route(s): | INTRAVENOUS; SUBCUTANEOUS |
Dosage Form(s): | INJECTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 64679-634 |
Labeler Name: | Wockhardt USA LLC. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA090986 |
Marketing Category: | ANDA |
Start Marketing Date: | 20110511 |
Package NDC: | 64679-634-01 |
Package Description: | 1 VIAL in 1 CARTON (64679-634-01) > 5 mL in 1 VIAL |
NDC Code | 64679-634-01 |
Proprietary Name | Octreotide acetate |
Package Description | 1 VIAL in 1 CARTON (64679-634-01) > 5 mL in 1 VIAL |
Product NDC | 64679-634 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Octreotide acetate |
Dosage Form Name | INJECTION |
Route Name | INTRAVENOUS; SUBCUTANEOUS |
Start Marketing Date | 20110511 |
Marketing Category Name | ANDA |
Labeler Name | Wockhardt USA LLC. |
Substance Name | OCTREOTIDE ACETATE |
Strength Number | 200 |
Strength Unit | ug/mL |
Pharmaceutical Classes | Somatostatin Analog [EPC],Somatostatin Receptor Agonists [MoA] |